Well well success sort of. At least we have met an
Post# of 586
(Total Views: 118)
Posted On: 08/19/2024 10:04:02 AM
Well well success sort of. At least we have met and submitted the FDA request and the clock is running on the PMA timeline!! 90 days and ticking!!!
United Health Products Submits Response Letter to FDA
9:09 AM ET 8/19/24 | GlobeNewswire
United Health Products Submits Response Letter to FDA
MT. LAUREL, NJ, Aug. 19, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval (PMA) application process.
Following the company's March 21 submission of its PMA application and the FDA's June 18 "Deficiencies Letter" to the company listing certain questions and comments on various elements of the application, on August 15, UHP submitted a Submission Issue Request to the FDA responding to certain questions and detailing its approach to addressing certain identified deficiencies.
The company has requested video conference with the FDA PMA application review team to discuss its responses and proposed solutions to the deficiencies. UHP anticipates the meeting to take place in early September.
UHP's Chief Executive, Brian Thom, commented: "We look forward to an interactive engagement with the FDA to gain clarity on what actions and information are needed in order to make a final determination on the merits of our PMA application."
The FDA's 180-day application review period, of which approximately 90 days have elapsed, will remain paused while the company engages further with the FDA and addresses any remaining deficiencies.
There can be no assurance that the company's PMA application will be approved.
$5-$10+
United Health Products Submits Response Letter to FDA
9:09 AM ET 8/19/24 | GlobeNewswire
United Health Products Submits Response Letter to FDA
MT. LAUREL, NJ, Aug. 19, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval (PMA) application process.
Following the company's March 21 submission of its PMA application and the FDA's June 18 "Deficiencies Letter" to the company listing certain questions and comments on various elements of the application, on August 15, UHP submitted a Submission Issue Request to the FDA responding to certain questions and detailing its approach to addressing certain identified deficiencies.
The company has requested video conference with the FDA PMA application review team to discuss its responses and proposed solutions to the deficiencies. UHP anticipates the meeting to take place in early September.
UHP's Chief Executive, Brian Thom, commented: "We look forward to an interactive engagement with the FDA to gain clarity on what actions and information are needed in order to make a final determination on the merits of our PMA application."
The FDA's 180-day application review period, of which approximately 90 days have elapsed, will remain paused while the company engages further with the FDA and addresses any remaining deficiencies.
There can be no assurance that the company's PMA application will be approved.
$5-$10+
(0)
(0)